Skip to main content
. 2024 Feb 19;15:1353029. doi: 10.3389/fphar.2024.1353029

FIGURE 2.

FIGURE 2

Effect of incretin-based therapies (alogliptin and semaglutide) and doxorubicin (DOX) on the kidney index. Data are represented as mean ± SEM. * is significant compared to the control group at p <0.05. # is significant compared to the DOX group at p <0.05.